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Abstract
Background: Mobile health (mHealth) presents one of the potential solutions to maximize health worker impact
and efficiency in an effort to reach the Sustainable Development Goals 3.1 and 3.2, particularly in sub-Saharan
African countries. Poor-quality clinical decision-making is known to be associated with poor pregnancy and birth
outcomes. This study aims to assess the effect of a clinical decision-making support system (CDMSS) directed at
frontline health care providers on neonatal and maternal health outcomes.
Methods/design: A cluster randomized controlled trial will be conducted in 16 eligible districts (clusters) in the
Eastern Region of Ghana to assess the effect of an mHealth CDMSS for maternal and neonatal health care services
on maternal and neonatal outcomes. The CDMSS intervention consists of an Unstructured Supplementary Service
Data (USSD)-based text messaging of standard emergency obstetric and neonatal protocols to providers on their
request. The primary outcome of the intervention is the incidence of institutional neonatal mortality. Outcomes
will be assessed through an analysis of data on maternal and neonatal morbidity and mortality extracted from the
District Health Information Management System-2 (DHIMS-2) and health facility-based records. The quality of
maternal and neonatal health care will be assessed in two purposively selected clusters from each study arm.
Discussion: In this trial the effect of a mobile CDMSS on institutional maternal and neonatal health outcomes will
be evaluated to generate evidence-based recommendations for the use of mobile CDMSS in Ghana and other West
African countries.
Trial registration: ClinicalTrials.gov, identifier: NCT02468310. Registered on 7 September 2015; Pan African Clinical
Trials Registry, identifier: PACTR20151200109073. Registered on 9 December 2015 retrospectively from trial start date.
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Background
The era of the Millennium Development Goals (MDGs)
has shown that with appropriate strategies and political
will, millions of lives can be improved and saved world-
wide [1, 2]. Maternal deaths were halved and under-5
mortality rate (U5MR) declined by more than half over
the 25 years of the MDGs [1]. Despite this success,
maternal, neonatal and child health care remains a
prominent public health concern, particularly in sub-
Saharan Africa and Southern Asia where most countries
did not attain MDGs 4 and 5 [2–5]. About 13.6 million
women are estimated to have died globally from mater-
nal causes between 1990–2015 [2]. An estimated
303,000 of these deaths occurred in 2015; 99% of them
occurred in low-and- middle income countries (LMIC)
and 66% in sub-Saharan Africa (SSA). Neonatal deaths
also accounted for 40% of the eight million childhood
deaths in 2010 [6–8]. Ninety-eight percent of these
neonatal deaths occurred in LMIC. Though there is
evidence of accelerating decline in maternal and U5MR
in all regions of the world [2, 3, 9, 10] the rate of decline
is uneven among countries [2, 11]. Inequalities still exist
in birth outcomes for mothers and their babies globally;
the lifetime risk of a woman dying from maternal causes
in SSA is 1 in 36 as compared to a lifetime risk of 1 in
4900 in high-income countries (HIC) [2]; neonates born
in SSA are six times more likely to die compared to neo-
nates born in HIC [12]. With regards to the decline of
U5MR, particularly in the early neonatal period only
minor declines have been achieved [9, 11]. It is projected
that the global composition of U5MR will continue to
shift towards a younger age structure, and that if
decreases in child mortality do not focus on neonatal
deaths, neonatal deaths will account for about 44.9% of
under-5 mortality by 2030 [3].
Maternal and neonatal deaths are caused by a complex
interaction of economic, financial, social, cultural and
clinical factors [13]. Clinical factors are related to access
and quality of antenatal care, skilled attendance at
delivery, emergency obstetric care services and postnatal
care for neonates. Gaps identified in the quality of care
(QOC) given to pregnant women and their newborns
include poor quality of clinical decision-making by health
providers. Besides knowledge acquired during education
in professional training institutions, health providers are
known to rely on past experiences, tacit knowledge and
intuition, referred to as “mind-lines” [14, 15], in making
clinical decisions for their patients. Different categories of
frontline providers deliver maternal and neonatal services
within and across various health facilities and as such their
experiences, intuitiveness and ability to learn from col-
leagues may vary as shown in differences in risk-taking
preferences and attitude towards risk which can lead to
significant variations in the way that decisions regarding
patient care are made [16]. Reliance on these mind-lines
may not be based on empirical evidence, and may affect
the QOC rendered to clients. These mind-lines, therefore,
cannot be depended upon for sustained QOC which is
needed to reduce maternal and neonatal morbidity and
mortality.
The use of information and communication technology
(ICT) in the form of mobile phones, commonly referred
to as mHealth, provides potentially important tools to
maximize health worker impact and efficiency [17, 18]
and improve service utilization [19] as global efforts to im-
prove maternal, neonatal and child health care intensifies
through the Sustainable Development Goals (SDGs) 3.1
and 3.2 already underway [20]. Generally, mHealth
interventions are well received by health workers and the
community [21]; however, data is limited as to their effect-
iveness on patient outcomes, efficiency of health systems
or their use by health workers [17, 19, 21–24]. Major areas
of application of mHealth interventions has been in the
area of tools and communication to support health
workers, adherence to treatment regime and data collec-
tion [21, 23]. Positive evidence for the applicability of
mHealth solutions suggest that mobile phones can
contribute in reducing the various phases of delay in
obtaining help for pregnant women, reducing program
cost and improving correct management of patients when
used as a decision-making tool [17, 21, 22, 25]. As mobile
phone penetration is high even in remote areas in SSA
[17] their use by health workers to deliver health care is
feasible irrespective of prior education or training in their
use [21, 24].
Ghana, a SSA country, is one of the 26 countries whose
U5MR contributed to 80% of the world’s childhood mor-
tality in 2013 [3]. The neonatal mortality rate is 29 deaths
per 1000 live births with higher mortality rates being
reported in rural areas of the country [26–28]. Ghana’s
maternal mortality is presently estimated at 319 per
100,000 live births [29]. Clinical causes of persistently high
maternal and neonatal mortality identified in Ghana
include nonadherence of health workers to clinical guide-
lines [30, 31]. Though the prevalence of antenatal clinic
(ANC) attendance among pregnant women is high in
Ghana, skilled attendance at birth is not optimal (about
74%) [27, 32]. Notable barriers to accessing skilled attend-
ance at birth in Ghana include cost, distance, availability
of health facilities and attitudes of nurses towards preg-
nant women [32, 33]. The importance of the QOC given
to pregnant women and their newborns for those who opt
for skilled attendance at delivery, can therefore not be
understated.
To help reduce maternal and neonatal mortality in
Ghana, we designed an mHealth intervention – a clinical
decision-making support system (CDMSS) facilitating
easy access to maternal and neonatal guidelines for
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routine and emergency obstetric, antenatal and neonatal
care for frontline providers of maternal and neonatal
care in Ghana. Our main study objective is to assess the
effect of CDMSS on the incidence of health facility-
based neonatal and maternal mortality.
Methods/design
Study design
A cluster randomized controlled trial (CRCT) to evaluate
the effect of a mobile clinical decision-making support sys-
tem on maternal and neonatal mortality and morbidity will
be conducted in 16 districts in the Eastern Region (ER) of
Ghana. This study will comprise three components: (1) a
baseline study to assess the characteristics of the health
facilities and outcome measures of interest in study sites,
(2) implementation of a CDMSS for 18 months and (3) a
sub-study to assess the QOC of maternal and neonatal care
services at baseline and at the end of the study.
Study site
The study will be conducted in the ER of Ghana. The
ER is the sixth largest region in terms of land area in
Ghana (Fig. 1). With an estimated mid-year population
of approximately 2.5 million, which is10.7% of the total
national population [34], the ER is the third most
populous region in Ghana. The region consists of 21 ad-
ministrative districts with Koforidua in the New Juaben
district as its regional capital. The ER is predominately
rural in nature with pockets of urban areas in mainly the
district capitals. About 40% of its inhabitants reside in 4
out of its 21 administrative districts. The most populous
districts are Afram Plains Kwahu North district, West
Akim district, Kwaebibirem and New Juaben district in
descending order. Agricultural (mainly fish and crop
farming) and mining activities are the main stay of eco-
nomic activities of the region. The estimated growth rate
of the ER is 2.0% [35].
Fig. 1 Map of districts in the Eastern Region of Ghana. The districts were defined as cluster units. Sixteen districts fulfilled our inclusion/exclusion
criteria. The regional capital, New Juaben Municipal, was excluded from the sampling to avoid selection bias as its regional hospital serves as the
highest referral point in the region
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Each district comprises a number of subdistricts that
form the administrative health subdistricts for the re-
gion. There are a total of 250 health facilities, including
31 hospitals in the region, that serve the health needs of
the region’s populace [35]. Like other parts of the coun-
try, the main categories of health care facilities in the ER
are – Community-based Health Planning and Services
(CHPS), health centres (HC) and maternity homes and
hospitals. At the primary health care level, the CHPS,
HC and maternity homes provide services, including
maternal and neonatal health services, to the various
communities and refer cases to the hospitals. The re-
gional neonatal mortality rate (NMR) was 29 per 1000
live births in 2008 [28]. From 2004 to 2014 the NMR of
the ER was estimated as 30 per 1000 live births, showing
little change over the period [27]. Presently, the ER
ranks sixth in terms of high NMR in Ghana [27]. The
pregnancy-related mortality ratio was also 594 per
100,000 live births in 2007 [36]. The ER was selected for
this study for two reasons: its high neonatal and mater-
nal mortality rates and because the intervention could
not be implemented in the Greater Accra region where
it had been designed and piloted [37].
Cluster selection criteria
The inclusion criteria for cluster selection for this study
include the following: (1) The district is located in the
ER, (2) The district has expected deliveries of at least
1100/year for the year 2014, (3) The District Health
Management Team and the District Hospital Manage-
ment Team agree to participate in the study and (4)
Health facilities within the district conducted at least
one delivery in the year 2014. The exclusion criteria for
our study are: (1) The district is located outside the ER,
(2) The district has expected deliveries of fewer than
1100/year for the year 2014, (3) The District Health
Management Team and the Hospital Management Team
do not agree to participate in the study and (4) Health
facilities within the districts have not conducted at least
one delivery during the year 2014.
The year 2014 was selected as the baseline year as the
most current data pertaining to deliveries (births) at the
time of commencement of the study was for that year. A
delivery (births) was a criterion for recruitment as most
obstetric and neonatal complications occur around
childbirth. Intervention during this period is crucial for
survival and health [38].
Sample size estimation
This study is a superiority trial and has been designed
and powered for neonatal mortality to contribute evi-
dence for improved neonatal health care considering the
predicted global upward trend in neonatal deaths [3]
compared to maternal deaths. Two formulae were
applied; the first formula was applied to estimate the re-
quired sample size in a randomized controlled trial
(RCT) with binary outcome while the second formula
was applied to inflate the estimated sample size for a
CRCT. Neonatal mortality is the primary outcome, and
is currently at approximately 30/1000 live births in the
ER, Ghana. Evidence from previous studies including
systematic reviews focusing on neonatal care interven-
tions have shown a 23% to 51% reduction in neonatal
mortality in settings including LIMC [39–44]. Our inter-
vention will also address neonatal and maternal health
care, hence we estimate an effect size of 30% on neo-
natal mortality with the use of this intervention.
Intracluster correlation coefficient (ICC) for neonatal
mortality in Ghana has been estimated at 0.0007256
[45]. To detect a 30% decline in neonatal mortality at a
power of 80%, a significance level of 0.05 (two-tailed
test), with a fixed number of eight clusters in each arm
of the study, approximately 1065 patients in each of the
16 clusters will be needed. The first formula is:
m ¼ n 1−ρð Þ
k−nρð Þ ;
where m = number of patients per cluster, k = number of
clusters in each arms of the study, ρ = ICC and n = is the
number of patients needed to detect this effect in a
RCT. The second formula is:
n ¼ θ π1 1−π1ð Þ þ π∘ 1−π∘ð Þ
π1−π∘ð Þ2
" #
where π1 = is the expected proportion of the neonatal
mortality at the intervention group after RCT, π∘ = is the
expected proportion of the neonatal mortality at the refer-
ence group after RCT and ϴ is the variance of the two pro-
portions at a power of 80% and significance level of 0.05.
Randomization
The study comprises two study arms – one intervention
and one control arm. A cluster unit was defined as a dis-
trict in this study. Twenty-one districts were, therefore,
eligible to be part of the study. Overall, 17 clusters fulfilled
the inclusion and exclusion criteria; however, the regional
capital was excluded from the selection process to avoid
selection bias as its regional hospital is the highest referral
point in the region. Sixteen clusters were, therefore, ran-
domized as shown in the trial flow chart (Fig. 2). Cluster
randomization was preferred over individual random-
ization to avoid contamination both at the health profes-
sional and client levels, which may occur as a result of
social interaction. Randomization was performed by an
independent data analyst in order to achieve comparability
and avoid selection bias. Randomization was carried out
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using STATA version 11.0 statistical software. Due to the
nature of this intervention, masking was not feasible.
Sampling of clusters for quality of care study
One well-resourced and one poorly resourced cluster
will be purposively selected from each study arm. The
selection criteria will be based on the number and mix
of health facilities in the district and the midwife to
number of deliveries (per annum) ratio in a district.
While purposive selection of these study districts does
not allow generalizability of findings, application of these
qualitative methods provides insight into how and why
the intervention worked or not.
The intervention
The intervention is a clinical decision-making support sys-
tem consisting of an Unstructured Supplementary Service
Data (USSD)-based text messaging of standard emergency
obstetric and neonatal protocols to providers on their re-
quest, based on the results of a formative study previously
conducted in the Greater Accra region [37]. As a reference
guideline the national Safe Motherhood Protocol (SMP)
[36], an elaborate tool that provides detailed state-of-the-
art guidelines for maternal and newborn care, ranging from
prenatal care, through antenatal, delivery, postpartum and
newborn care, was chosen. A committee of medical experts
designed concise and precise protocols with respect to
word limits using the USSD system and short protocols
using USSD templates have been generated. Access to the
USSD platform will be limited to a closed user group
(intervention group) who will be provided with subscriber
identity module (SIM) cards and cell phones by the re-
search team to avoid contamination. To support the use of
the USSD-based text messaging system by health care pro-
viders, health care providers in the intervention districts
will receive monthly reminders via short messaging service
(SMS) on the applicability of the text messaging system for
clinical decision-making.
Text messaging based on the USSD system was chosen
as a low-cost, easily accessible and instant way of
requesting needed information during routine and emer-
gency situations by the health care provider to enhance
clinical decision-making. To access the USSD platform,
health care workers send a text to a specified short code
and this assists in the rapid sharing of the needed infor-
mation. Access to the USSD platform is free and un-
limited. The USSD platform is linked to the general
electronic data platform of a telecommunication com-
pany whose policy and practice assures 99.99% avail-
ability of the general electronic data platform. However,
availability of phone reception to assess the network
may differ according to location of health facilities.
Monitoring
Uptake of the intervention will be monitored by the fre-
quency of intervention usage using data about requests
made to the USSD collected by the telecommunication
company providing technical support for the USSD. All
Fig. 2 Trial flow chart showing cluster selection, assignment and timelines of the cluster randomized controlled trial (CRCT). Clusters that fulfilled
the inclusion and exclusion criteria were randomized into eight control and eight intervention clusters. The CRCT started in August 2015 and
ends in January 2017. Activity, purple oblong; Timeline. orange oblong.
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health facilities in the intervention arm will be visited
periodically to assess the functionality of the interven-
tion on site. Research assistants (in this case, district
health information officers have been recruited) will be
trained to supervise data collection activities in the non-
hospital facilities in all clusters and to provide updates
concerning challenges providers may face with the use
of the USSD platform to the research team. The super-
visory role of the district health information officers
includes ensuring that documentation from the non-
hospital facilities is complete and collation of completed
data collection forms for submission to the project team.
The district health information officers will not make
any changes to what is recorded on the completed
forms. Thus, they will not assess morbidity or mortality
causation.
Data collection
Data about district and facility characteristics in both
arms of the study using a structured questionnaire will
be collected. These include human and logistical re-
sources, ANC attendance, number of deliveries, obstetric
and neonatal admissions, and primary and secondary
outcomes at the baseline and at the end of the study.
The impact of the intervention will be evaluated by ex-
traction of data of outcome measures of interest from
the district health information management system-2
(DHIMS-2) database which has been shown to provide
reliable estimates of measures [46, 47]. This study will
assess the effect of a CDMSS on the commonest causes
of neonatal and maternal morbidity and mortality in
Ghana. Protocols for diagnosis of these conditions are
standardized by the Ghana Health Service across the dif-
ferent categories of health facilities, hence diagnosis
across facility type are similar. We assume that health
care workers make accurate diagnosis of these common
sources of morbidity most of which diagnosis can be
made using physical examination and rapid diagnostic
tests. The diagnoses made by these health care workers
across the different categories of health facilities forms
the basis of data entered in the DHIMS-2. Details of all
the outcome measures the CRCT seeks to extract from
the DHIMS-2; however, covers only hospital data. The
non-hospital health facilities report only aggregate data
through their district health directorate into the
DHIMS-2. Details of outcome measures of interest to
the CRCT will, therefore, be collected at the facility level
for non-hospital facilities participating in the trial. The
diagnosis will be based on what is recorded in the
DHIMS-2 or what is recorded in the facility health rec-
ord books by the health care providers as these diagno-
ses are expected to follow the standard case definitions
for Ghana. Availability of network connectivity in health
facilities will be measured during the postintervention
evaluation using a Likert scale administered to the
health care providers.
The QOC of neonatal and maternal health care
services will be assessed by measuring health provider
adherence to the standard emergency protocols at base-
line and at the end of the study. Provider adherence to
these protocols for common neonatal and maternal con-
ditions will be assessed using a checklist based on the
SMP in use in Ghana. Qualitative assessment (focus
group discussions and key informant interviews among
health care workers) as to how the intervention was
used and why it produced the effects observed will be
conducted in the two intervention districts where the
QOC study will be conducted.
All data will be collected in an anonymous format.
Double entry of data collected will be done and data will
be handled in accordance with Good Clinical Practice.
Figure 3 summarizes the schedule of enrollment and
time points for assessments for this study.
Outcome measures
Institutional neonatal mortality will be considered as the
primary outcome measure for this study. For this study
neonatal mortality is defined as death of a newborn
occurring from birth up to the 28th day of life [12].
Multiple secondary outcome measures pertaining to
maternal and neonatal outcomes will also be measured.
Aggregate data on primary and secondary outcomes will
be extracted from (DHIMS-2) and health facility health
record books for non-hospital facilities (Table 1).
Statistical analysis
Data analysis and reporting will be in line with the Con-
solidated Standards of Reporting Trials (CONSORT)
Statement guidelines [48]. In this study, randomization
was done at the district level and not at the health facil-
ity level. All health facilities within a district, therefore,
form a cluster. Clusters may differ slightly in their
characteristics as can be seen in the larger number of
non-hospital health facilities in the control arm (Table
2). We will conduct descriptive analysis of both inter-
vention and reference groups at baseline to explore po-
tential differences in study baseline characteristics of
clusters and participants in both study arms. To assess
the risk of imbalance in baseline characteristics among
the clusters, we will use the c-statistic of the propensity
score model of the study. The c-statistic of the propen-
sity score model of the study is considered an appropri-
ate tool to detect baseline imbalance in CRCTs where
sample size is large and when a large number of covari-
ates are measured [49]. Any observed imbalance in the
baseline characteristics of clusters will be adjusted for in
the statistical analysis.
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The effect of the CDMSS on primary and secondary
outcomes will be analyzed based on the principle of
intention-to-treat to minimize over-estimation of the
effect of the intervention. Logistic regression will be
applied to investigate the effect of CDMSS on all out-
come measures considering a potential clustering effect
of the CRCT design and adjusting for potential con-
founders. Results will be reported as relative risks with
corresponding 95% confidence intervals. A two-tailed
statistical significant level of 0.05 will be used. Among
clusters in the intervention arm, descriptive analysis of
the availability of network connectivity in health facilities
will be done and any significant difference in network
availability will be adjusted for using logistic regression.
STATA software package [50] and MLwiN software
version 2.1 [51] will be employed to handle the analysis.
Descriptive analysis of the adherence of health care
providers to standard maternal and neonatal protocols
will be done by cluster. Logistic regression will be
applied to investigate the association between health
provider adherence to protocols and the incidence of
maternal and neonatal mortality. Responses from focus
group discussions and key informant interviews will be
manually transcribed, analyzed and grouped into various
themes emphasizing the key convergent and divergent
views that explain how and why the health care
providers adhered, or did not adhere, to the intervention
protocols.
Fig. 3 Schedule of enrollment, intervention allocation and assessment using Standard Protocol Items: Recommendations for Interventional Trials
(SPIRIT) figure for study protocols
Table 1 Data sources for outcome measures
Outcome measure Source of data
Hospital Health centre CHPS Maternity home
Number of cases of birth asphyxia DHIMS-2 Facility Facility Facility
Number of cases of low birthweight DHIMS-2 Facility Facility Facility
Number of cases of neonatal jaundice DHIMS-2 Facility Facility Facility
Number of cases of neonatal sepsisa DHIMS-2 Facility Facility Facility
Number of cases of PIH/pre-eclampsia/eclampsia DHIMS-2 Facility Facility Facility
Number of cases of postpartum hemorrhage DHIMS-2 Facility Facility Facility
Number of cases of prolonged labor DHIMS-2 Facility Facility Facility
Number of cases of puerperal sepsis DHIMS-2 Facility Facility Facility
Number of cases of neonatal deaths DHIMS-2 Facility Facility Facility
Number of cases of maternal deaths DHIMS-2 DHIMS-2 DHIMS-2 DHIMS-2
Total number of deliveries DHIMS-2 DHIMS-2 DHIMS-2 DHIMS-2
Total number of ANC attendants DHIMS-2 DHIMS-2 DHIMS-2 DHIMS-2
aCord sepsis used as a proxy for neonatal sepsis in this study; ANC antenatal clinic, CHPS Community-based Health Planning and Services, DHIMS-2 District Health
Information Management System-2, PIH pregnancy-induced hypertension
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Expected outcome
This intervention is expected to improve clinical
decision-making which will lead to a decline in maternal
and neonatal deaths (Fig. 4). Neonatal and maternal
mortality rates based on the number of live births, neo-
natal deaths, including perinatal deaths, and the number
of maternal deaths in each cluster as well as in each arm
will be estimated. These rates estimated will be com-
pared to the rates before the intervention.
Recruitment and consent of participants
The intervention has been designed for use by frontline
providers of maternal and neonatal health care services
to support users in making clinical decisions regarding
their clients. The impact of the intervention will be mea-
sured by extracting data about maternal and neonatal
participants who seek care from frontline workers work-
ing in health facilities participating in this study (Table 2).
Maternal and neonatal participants will be indirectly re-
cruited into this study. Consent to participate in the study
was, therefore, sought from the heads of the District
Health Management Team, the Hospital Management
Team and heads of non-hospital health facilities in the
randomized clusters. Prior consultation was held with the
Eastern Regional Health directorate team before commen-
cing the research. Written informed consent was sought
from all heads of participating district health directorates
and health facilities prior to the enrollment of the health
facilities into the study. Processes to assure privacy, confi-
dentiality and free choice to withdraw from this study dur-
ing the conduct of the trial were explained in the Consent
Form. Signatures were collected as evidence of consent.
Benefits and risk
This intervention is not invasive. Participants are at min-
imal risk for being part of the study. However, the pro-
vider’s standard of health care delivery is being assessed
and thus they may feel a little uncomfortable. The re-
searchers will bear this in mind and ensure that this is
minimized by assuring providers of anonymity and con-
fidentiality. This study will enable health care profes-
sionals to enhance service delivery through access to
CDMSS in the case of randomization into the interven-
tion group. Potential benefit to the provider is enhanced
service delivery, while to the client the benefit is indirect
and long-term. This is because the intervention aims at
quality improvement of maternal and neonatal health
service delivery.
Discussion
We have described the protocol for a CRCT to evaluate
the effect of an mHealth clinical decision-making sup-
port system compared to routine care on maternal and
neonatal mortality and morbidity in a context of high
maternal and neonatal mortality using the Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) Checklist (see Additional file 1) [52]. A
CRCT is preferred in this kind of intervention to
minimize contamination within clusters and optimize
scalability of the intervention in a real-life context. This
CRCT is being implemented with the support of the re-
gional and local health managers who supervise the
work of the frontline health workers. The implementa-
tion process of this trial will be well documented. If suc-
cessful, this CRCT will provide evidence for the use of
an mHealth-based CDMSS to reduce maternal and neo-
natal mortality facilitating the attainment of the SDGs.
Lessons learnt from this CRCT can inform recommen-
dations to design and upscale mHealth interventions
within the Ghana Health Service system as a whole and
in other LMIC, particularly in West Africa. This CRCT
will also provide the opportunity to get to know how
frontline health workers will use an mHealth interven-
tion to support their clinical decision-making. Data gath-
ered from the requests made to the USSD platform will
provide insight into the information needs of frontline
health workers of maternal and neonatal contributing to
Fig. 4 Conceptual framework for evaluating the effect of a clinical
decision-making support system (CDMSS) on maternal and neonatal
mortality and morbidity in Ghana (2016). The intervention includes
training of frontline health workers to utilize the unstructured
supplementary service data. The impact of the intervention will be
assessed by measuring maternal and neonatal deaths
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recommendations for training programs for frontline
health workers.
Though this study will provide much needed evidence
to bridge the knowledge gap about the effect of mHealth
intervention on maternal and neonatal health outcomes,
the study has some limitations. Firstly, we assume that
once the USSD platform is assessed, the information re-
trieved will be used for action; this may not always be
the case. We expect that the assessment of the QOC of
maternal and neonatal health care services in the four
purposively selected clusters will address this limitation
to a large extent. Secondly, there is generally a limitation
with regard to network availability, electricity and well-
functioning phones in Ghana, particularly in the rural
areas; this may affect the ability of health care providers
in some remote areas to use the intervention. Thirdly,
this study will not assess neonatal or maternal mortality
at the community level. The attributable risk of death
for neonates born at home compared to those born in
health facilities in SSA is estimated to be 21% [53]. The
DHIMS-2 database from which data for evaluation of
the CRCT will be extracted is a web-based platform built
on the District Health Information System-2 (DHIMS-2)
open source software. DHIMS-2 serves as a data record-
ing, collection, collation and analysis tool that hosts the
entire national health data of Ghana. Data entry into the
DHIMS-2 is done using primary data collection tools
and standard registers designed for various health ser-
vices and programs. The DHIMS-2 does not capture
community-level health outcomes. The contribution of
out-of-facility deaths to maternal and neonatal mortality
is, therefore, not captured in the DHIMS-2. The CDMSS
has also been implemented as an institutional-based
support system to be used by health facilities that con-
tribute data to the DHIMS-2. Thus, community-level
data (contribution of the out-of-health facility deliveries
to neonatal and maternal deaths) will not be assessed in
this study. However, given that 74% of deliveries in
Ghana occur in a health facility with a skilled attendant
[27], we expect our sample to include the majority of
maternal and neonatal clients because clients who self-
select to deliver at health facilities are usually followed
up in the communities by the health workers. These
clients are likely to seek health care services from these
facilities. Lastly, there may be concurrent maternal and
neonatal health care interventions running at the time of
the trial. These interventions could influence the results
of our study although they are likely to be independent
from the randomization. However, the study team will
document all concurrent maternal and neonatal health
services occurring in the study sites and carefully inter-
pret our results based on this real-life context.
Trial status
The trial was registered at ClinicalTrials.gov on 7
September 2015 (trial identifier: NCT02468310) and the
Pan African Clinical Trials Registry on 9 December 2015
(trial identification number: PACTR20151200109073).
Registration at the Pan African Clinical Trials Registry
was done retrospectively after the trial commenced. The
recruitment for the trial commenced on 10 August 2015
and is expected to be completed by the end of January,
Table 2 Number of health facilities participating in the cluster randomized controlled trial (CRCT)
Districta Arm Hospitalb Health centres CHPS Maternity home
District 1 Intervention 1 1 7 0
District 2 Control 2 6 10 1
District 3 Intervention 1 7 3 0
District 4 Control 1 5 4 1
District 5 Intervention 3 2 9 1
District 6 Control 1 6 7 0
District 7 Intervention 1 3 3 0
District 8 Control 3 4 6 2
District 9 Control 1 3 5 1
District 10 Intervention 3 2 0 1
District 11 Intervention 1 3 2 0
District 12 Intervention 1 8 1 1
District 13 Control 1 7 5 1
District 14 Control 3 6 1 0
District 15 Control 2 4 3 0
District 16 Intervention 1 3 3 1
aDistricts have been renamed 1 to 16 for anonymity; bHospitals include private hospitals in clusters; CHPS Community-based Health Planning and Services
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2017. During the initial 6 months of the CRCT, there
were over 2500 requests made to the USSD platform.
These requests were made from 94% of health facilities
participating in the CRCT.
Additional file
Additional file 1: SPIRIT 2013 Checklist: recommended items to address
in a clinical trial protocol and related documents. (PDF 964 kb)
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